Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis

被引:36
|
作者
Christensen, JH
Siggaard, C
Corydon, TJ
DeSanctis, L
Kovacs, L
Robertson, GL
Gregersen, N
Rittig, S
机构
[1] Aarhus Univ Hosp, Dept Pediat, Skejby Sygehus, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Pediat Res Lab, Skejby Sygehus, DK-8200 Aarhus, Denmark
[3] Univ Aarhus, Dept Human Genet, Aarhus, Denmark
[4] Univ Turin, Dept Pediat, Turin, Italy
[5] Comenius Univ, Comenius Univ Med Sch, Bratislava, Slovakia
[6] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[7] Aarhus Univ Hosp, Res Unit Mol Med, Skejby Sygehus, DK-8200 Aarhus, Denmark
关键词
diabetes insipidus; AVP gene; mutation; neurohypophyseal; autosomal dominant; neurophysin II;
D O I
10.1038/sj.ejhg.5201086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI) is caused by postnatal arginine vasopressin (AVP) deficiency resulting from mutations in the AVP gene encoding the AVP preprohormone. To advance the understanding of adFNDI further, we have searched for mutations in the AVP gene in 15 unrelated kindreds in which diabetes insipidus appeared to be segregating. In nine kindreds, seven different previously described mutations were identified. In each of the other six kindreds, unique novel mutations were identified. Two of these (225A>G and 227G>A) change a nucleotide in the translation initiation codon of the signal peptide, whereas the other four (1797T>C, 1884G>A, 1907T>G, and 2112C>G) predict amino-acid substitutions in the neurophysin II moiety of the AVP prohormone, namely V67A (NP36), G96D (NP65), C104G (NP73), and C116W (NP85). Among these, the mutation predicting the V67A ( NP36) substitution is remarkable. It affects a region of the neurophysin II not affected by any other mutations, produces only a minor change, and its inheritance suggests an incomplete penetrance. Our findings both confirm and further extend the mutation pattern that has emerged in adFNDI, suggesting that the mutations affect amino-acid residues known or reasonably presumed to be important for the proper folding and/or dimerization of the neurophysin II moiety of the AVP prohormone.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 50 条
  • [31] Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene
    Fujii, H
    Iida, S
    Moriwaki, K
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 5 (03) : 229 - 234
  • [32] Two novel mutations in seven Czech and Slovak kindreds with familial neurohypophyseal diabetes insipidus-benefit of genetic testing
    Hrckova, Gabriela
    Janko, Viktor
    Kytnarova, Jitka
    Cizmarova, Michaela
    Tesarova, Marketa
    Kost'alova, L'udmila
    Virgova, Daniela
    Dallos, Toma
    Hana, Vaclav
    Lebl, Jan
    Zeman, Jiri
    Kovacs, Laszlo
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (09) : 1199 - 1207
  • [33] A MISSENSE MUTATION IN THE VASOPRESSIN-NEUROPHYSIN PRECURSOR GENE COSEGREGATES WITH HUMAN AUTOSOMAL DOMINANT NEUROHYPOPHYSEAL DIABETES-INSIPIDUS
    BAHNSEN, U
    OOSTING, P
    SWAAB, DF
    NAHKE, P
    RICHTER, D
    SCHMALE, H
    EMBO JOURNAL, 1992, 11 (01): : 19 - 23
  • [34] Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin–neurophysin II gene
    Yongfeng Luo
    Binbin Wang
    Yu Qiu
    Chuan Zhang
    Chengluo Jin
    Yakun Zhao
    Qingguo Zhu
    Xu Ma
    Endocrine, 2012, 42 : 208 - 213
  • [35] Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) caused by a novel mutation in the hormone-codng region of the vasopressin-neurophysin gene.
    Wahlstrom, JT
    Fowler, MJ
    Kovacs, WJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S273 - S273
  • [36] Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) caused by a novel mutation in the hormone-codng region of the vasopressin-neurophysin
    Wahlstrom, JT
    Fowler, MJ
    Kovacs, WJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S304 - S304
  • [37] Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene
    Luo, Yongfeng
    Wang, Binbin
    Qiu, Yu
    Zhang, Chuan
    Jin, Chengluo
    Zhao, Yakun
    Zhu, Qingguo
    Ma, Xu
    ENDOCRINE, 2012, 42 (01) : 208 - 213
  • [38] Novel germline p.Ala72Glu AVP mutation in a family with autosomal dominant familial neurohypophyseal diabetes insipidus
    Koehler, V. F.
    Van der Haegen, U.
    Mann, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 122 - 122
  • [39] Dilatative Uropathy as a Manifestation of Neurohypophyseal Diabetes Insipidus due to a Novel Mutation in the Arginine Vasopressin-Neurophysin-II Gene
    Lindenthal, V.
    Mainberger, A.
    Morris-Rosendahl, D. J.
    Loening, L.
    Mayer, W.
    Mueller, H. L.
    KLINISCHE PADIATRIE, 2013, 225 (07): : 407 - 412
  • [40] Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus
    Bullmann, C
    Kotzka, J
    Grimm, T
    Heppner, C
    Jockenhövel, F
    Krone, W
    Müller-Wieland, D
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (03) : 134 - 137